Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Si-Ware Systems is a private deep-tech sensing company that develops MEMS- and optics-based sensing technologies, embedded systems, AI-enabled software, and full-stack sensing solutions for industrial and OEM customers. The company originated as a semiconductor and MEMS technology developer and today markets material sensing products, sensor-control software, and multi-sensor platforms spanning agriculture, manufacturing, and other non-therapeutic end markets. Its best-known platform has been NeoSpectra, a family of FT-NIR spectrometers and related cloud software, although the company states that the NeoSpectra business was acquired by Buchi in 2025. Si-Ware now highlights a broader portfolio including Si-NIR Mini, Si-NIR Matrix, AgriLIMS, CropScout, and custom sensing solutions that combine hardware, software, and systems integration. While its technologies can be used in life-science or healthcare-adjacent analytical workflows, Si-Ware is not primarily a biotech, pharma, or healthcare therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Si-Ware Systems.